Valuation: DNA X, Inc.

Market Cap 5.05M 4.39M 4.08M 3.75M 7.08M 482M 7.19M 48.15M 18.9M 240M 18.96M 18.54M 804M P/E 2024
-0.44x
P/E 2025 -0.11x
Enterprise Value 8.81M 7.66M 7.13M 6.54M 12.36M 841M 12.55M 84.03M 32.98M 419M 33.09M 32.36M 1.4B EV / Sales 2024
0.17x
EV / Sales 2025 -
Free-Float
63.9%
Yield 2024 *
-
Yield 2025 -
1 day+4.37%
1 week+7.66%
1 month-35.51%
3 months-30.63%
6 months-39.86%
Current year+7.68%
1 week 3.02
Extreme 3.02
3.39
1 month 2.8
Extreme 2.8
4.69
Current year 2.62
Extreme 2.62
7.97
1 year 2.52
Extreme 2.5211
16.97
3 years 2.52
Extreme 2.5211
192.6
5 years 2.52
Extreme 2.5211
1,322.28
10 years 2.52
Extreme 2.5211
32,863.47
Manager TitleAgeSince
Chief Executive Officer 63 2026-02-08
Director of Finance/CFO 64 2022-07-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 63 2023-11-12
Director/Board Member 64 2022-07-12
Director/Board Member 79 2022-07-12
Date Insider Type Main position Quantity % Market Cap.
2/9/26 Free

Chief Executive Officer

50,000 3.3592%
2/9/26 Free

Chief Financial Officer

35,000 2.3514%
7/18/25 Other

Director

723 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
+4.37%+7.66%-70.36%-98.12% 5.05M
+26.81%+5.21%+280.99%+269.20% 1,161B
+0.50%+13.11%-19.40%+26.07% 1.84B
+1.90%+10.63%+32.72%+317.83% 1.35B
+5.55%-4.31%-2.08%-28.15% 1.03B
+13.49%-4.69%+65.05%+24.70% 988M
+3.20%+6.45%+6.63%+205.81% 594M
+18.20%-4.40%-16.77%+37.59% 527M
+3.00%+4.13%+13.86%-11.27% 420M
+0.83%+3.54%-22.13%+290.19% 184M
Average +7.78%+2.76%+26.85%+103.39% 116.83B
Weighted average by Cap. +26.68%+3.35%+279.38%+268.17%

Financials

2024 2025
Net sales 58.3M 50.68M 47.17M 43.31M 81.78M 5.57B 83.05M 556M 218M 2.77B 219M 214M 9.29B -
Net income -33.65M -29.25M -27.23M -25M -47.2M -3.21B -47.93M -321M -126M -1.6B -126M -124M -5.36B -20.66M -17.96M -16.71M -15.35M -28.98M -1.97B -29.43M -197M -77.32M -982M -77.58M -75.88M -3.29B
Net Debt -5.34M -4.64M -4.32M -3.97M -7.5M -510M -7.61M -50.96M -20M -254M -20.07M -19.63M -851M 3.76M 3.27M 3.04M 2.79M 5.28M 359M 5.36M 35.88M 14.08M 179M 14.13M 13.82M 600M
Logo DNA X, Inc.
DNA X, Inc., formerly Sonim Technologies, Inc., is a digital asset management platform, building on the digital asset trading platform. The Company operates an artificial intelligence (AI) and crypto trading platform designed to automate trading strategies using machine learning technologies. It provides a digital asset trading platform that allows users to trade or swap cryptocurrencies for other cryptocurrencies or cash equivalent currencies. The Company’s DNA X trading website enables users to implement strategies to take advantage of fluctuations in relative values of cryptocurrency pairs. The platform allows users to set up automated trading strategies, monitor other traders’ trading strategies in real time, and simulate trades. The Company generates revenue from trading commissions based on the value of trades executed on its platform. It serves individual investors from around the world and supports its operations through subsidiaries located in China, Germany, and Hong Kong.
Employees
4
Date Price Change Volume
26-07-31 $3.392 +4.37% 7,573
26-07-30 $3.250 +4.50% 4,493
26-07-29 $3.110 +2.64% 17,546
26-07-28 $3.030 -5.02% 2,340
26-07-27 $3.190 +1.24% 4,298

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SONM Stock